Project Grant R01DA064492
- This federal Project Grant award of $769,708 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is for the "Drug Use and Addiction Research Programs" (CFDA 93.279). The award supports research to adapt and pilot test the Brief Negotiation Interview (BNI) for use among assault-injured emerging adults (ages 18-25) with alcohol and/or cannabis misuse who seek care in the emergency department setting. Key objectives include eliciting shared...
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...
- This $750,151 Project Grant was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a natural experiment study to examine the impacts of legislation (HB-139) eliminating court fees in New Mexico on substance use outcomes, including drug court engagement and statewide overdose mortality. The study will utilize data from New Mexico's unified court system and...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award of $742,500 from the National Institute on Drug Abuse (NIDA), which is part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on a peer recovery coaching intervention to promote tobacco abstinence among individuals with opioid use disorder. The award will fund a 3-year pilot study to adapt a behavioral tobacco use disorder (TUD) intervention called PEERTTS for people with opioid use disorder and TUD, and to train peer recovery...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This federal Project Grant award of $770,461.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "Police Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study", aims to investigate implementation gaps in police-assisted diversion (PAD) programs that link people who use drugs (PWUD) to treatment and services, especially medications for opioid use disorder. The project...
- This Project Grant award of $400,000 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Mountainpass Technology LLC, a for-profit company in Chevy Chase, Maryland. The funding will support the development of "MyTrials", an integrated remote biomarker capture system for decentralized clinical trials focused on substance use disorders. The project aims to address key methodological limitations in remote...
This federal Project Grant award of $661,850 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a hybrid Type I trial to assess the effectiveness and implementation of a peer-led court navigator program that facilitates linkage to substance use disorder treatment. The award will fund a randomized controlled trial to compare the effectiveness of the court navigation intervention, delivered by certified peer recovery specialists, against an information-only control in two Indiana courthouses. The project aims to test whether this innovative court-based approach can improve linkages to substance use treatment for justice-involved individuals with behavioral health needs. The award was made on September 30, 2025 with a scheduled ultimate completion date of May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $661.9k | 9/16/25 |